| Patient | Ulysses S. Grant |
|---|---|
| Date of birth | 1822-04-27 |
| Identifiers | MRN HR-NI002-SYN-TD; SSN (made up) 000-02-9416 |
| Document date | 1884-10-22 |
| Author | Corinne Batiste, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Primary care review three weeks after chemoradiation. [S]
Mr. Grant returns three weeks after finishing chemoradiation, directed by the head and neck oncology team, for p16-negative squamous cell carcinoma of the right tonsillar pillar. His throat pain has eased to 3 of 10. He takes the acetaminophen solution once or twice a day and rarely needs the lidocaine rinse. His mouth is dry and food tastes muted, so he sips water with every mouthful. He eats soft foods with two supplement drinks a day and did not need a feeding tube. He weighs 71.0 kg, 7 kg below his weight at intake. He has smoked no cigars since mid-July and continues varenicline 1 mg twice daily without side effects. His energy is slowly returning and he writes for two to three hours a day. He has had no fever, bleeding, choking, or new lumps in the neck, and no change in his hearing. He uses fluoride gel in trays each night, as the dentist advised before radiation. [S]
| Element | Detail |
|---|---|
| Treatment | Chemoradiation completed three weeks ago |
| Pain | 3 of 10; acetaminophen once or twice a day; lidocaine rinse rarely |
| Late effects | Dry mouth and muted taste; no choking |
| Weight and nutrition | 71.0 kg, 9 percent below intake; no feeding tube needed |
| Tobacco | No cigars since mid-July; varenicline continued |
| Function | Energy returning; writing two to three hours a day |
| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Fatigue, improving; no fever or night sweats |
| Ears, nose, mouth, and throat | Positive | Dry mouth, muted taste, and throat pain 3 of 10; no hearing change or ear pain |
| Respiratory | Negative | No cough, choking with liquids, or breathlessness |
| Gastrointestinal | Negative | No nausea or vomiting; bowels regular |
| Integumentary | Positive | Darkened, dry skin on the neck from radiation, healing |
| Hematologic | Negative | No bruising or bleeding |
| Psychiatric | Negative | Mood steady; PHQ-2 score 1 |
7 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Varenicline 0.5 mg oral tablet, one tablet daily for three days, then one tablet twice daily | One tablet by mouth daily for three days, then twice daily | Oral route | 1884-07-07 to 1884-07-21 | completed | S |
| Varenicline 1 mg oral tablet, one tablet twice daily | One tablet by mouth twice daily after meals | Oral route | 1884-07-21 | active | S |
| Acetaminophen 160 mg/5 mL oral solution, 20 mL (640 mg) every 6 hours as needed for throat pain | 20 mL by mouth every 6 hours as needed for pain; no more than 3,000 mg a day | Oral route | 1884-07-07 | active | S |
| Lidocaine viscous 2% solution, 15 mL swish and spit up to every 3 hours as needed for throat pain | Swish 15 mL and spit up to every 3 hours as needed, no more than 8 doses a day; do not eat or drink for 60 minutes after use | Topical route | 1884-07-07 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1884-10-22 | Body height | 173 | cm | S |
| 1884-10-22 | Body weight | 71 | kg | S |
| 1884-10-22 | Body mass index (BMI) [Ratio] | 23.7 | kg/m2 | S |
| 1884-10-22 | Systolic blood pressure | 118 | mm[Hg] | S |
| 1884-10-22 | Diastolic blood pressure | 72 | mm[Hg] | S |
| 1884-10-22 | Heart rate | 84 | /min | S |
| 1884-10-22 | Respiratory rate | 16 | /min | S |
| 1884-10-22 | Body temperature | 36.9 | Cel | S |
| 1884-10-22 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1884-10-22 | Hemoglobin [Mass/volume] in Blood | 11.9 | g/dL | 13.2-16.6 g/dL | Low | S |
| 1884-10-22 | Leukocytes [#/volume] in Blood by Automated count | 3.6 | 10*3/uL | 4-11 10*3/uL | Low | S |
| 1884-10-22 | Platelets [#/volume] in Blood by Automated count | 168 | 10*3/uL | 150-400 10*3/uL | Normal | S |
| 1884-10-22 | Sodium [Moles/volume] in Serum or Plasma | 136 | mmol/L | 135-145 mmol/L | Normal | S |
| 1884-10-22 | Potassium [Moles/volume] in Serum or Plasma | 4 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1884-10-22 | Creatinine [Mass/volume] in Serum or Plasma | 1.12 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 1884-10-22 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1879)/1.73 sq M | 74 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1884-10-22 | Glucose [Mass/volume] in Serum or Plasma | 94 | mg/dL | 70-99 mg/dL | Normal | S |
| 1884-10-22 | Albumin [Mass/volume] in Serum or Plasma | 3.3 | g/dL | 3.5-5 g/dL | Low | S |
| 1884-10-22 | Pain severity - 0-10 verbal numeric rating [Score] - Reported | 3 | {score} | S | ||
| 1884-10-22 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 1 | {score} | S |
Vital signs recorded on 1884-10-22; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Thinner, alert, and in good spirits |
| Oropharynx | Dry mucosa; the treated right tonsillar area is healing, with no ulcer or visible mass |
| Neck | Healing radiation skin changes; firm tissue on the right with no discrete node |
| Lungs | Clear |
| Heart | Regular rhythm; no murmur |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Squamous cell carcinoma of the right tonsillar pillar, p16-negative, suspected at presentation and confirmed by biopsy at the otolaryngology visit; linked to the documented 1885 diagnosis | active | confirmed | C09.1 | S — Synthetic diagnosis in the modern episode; the 1884-1885 findings remain D. |
| Nicotine dependence, cigars, about ten a day for more than forty years | active | confirmed | F17.290 | S — Synthetic modern diagnosis linked to documented heavy cigar smoking. |
| Painful swallowing with oropharyngeal dysphagia from the tonsillar tumor | active | confirmed | R13.12 | S — Synthetic symptom diagnosis echoing the documented painful swallowing. |
| Unintended weight loss from painful swallowing, about 2 kg before presentation | active | confirmed | R63.4 | S — Synthetic finding from the measured weights. |
| Acute viral bronchitis after a head cold during the cancer workup, resolved without antibiotics | resolved | confirmed | J20.9 | S — Synthetic intercurrent illness at an unscheduled visit; it does not echo a documented illness. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Laboratory | CBC, basic metabolic panel, and albumin | Before and after treatment | Completed today | Hemoglobin 11.9 and white count 3.6, both low after treatment; platelets 168; sodium 136, potassium 4.0, creatinine 1.12, eGFR 74, glucose 94; albumin 3.3, low |
| Laboratory | Repeat CBC and basic metabolic panel | Until counts and kidney function recover | Due | In four to six weeks |
| Laboratory | TSH | Every 6 to 12 months after neck radiation | Due | Baseline 1.8 mIU/L; first check about six months after treatment |
| Examination | History and head and neck examination | Every 1 to 3 months in the first year after treatment | Completed today | No ulcer, mass, or discrete neck node; laryngoscopy at the head and neck oncology follow-up |
| Referral | Head and neck oncology follow-up with laryngoscopy | Every 1 to 3 months in the first year after treatment | Due | First post-treatment review with the head and neck team in the coming weeks |
| Imaging | Post-treatment PET/CT | At least 12 weeks after treatment, within 6 months | Due | About nine weeks from now, arranged by the head and neck team |
| Imaging | Lung cancer screening with low-dose CT | Annually for eligible current and former smokers | Not indicated | Screening eligibility is defined by cigarette pack-years, and his tobacco use was cigars; the post-treatment PET/CT includes the chest |
| Examination | Weight | Every visit | Completed today | 71.0 kg, 9 percent below baseline; goal of less than 10 percent loss met |
| Survey | Throat pain score (0-10) | Every visit | Completed today | 3 of 10 |
| Survey | Depression screen (PHQ-2) | Every primary care visit after the diagnosis | Completed today | Score 1 |
| Survey | PHQ-9 after a PHQ-2 score of 2 or more | Whenever the PHQ-2 is 2 or more | Deferred | The PHQ-2 of 2 at the pre-treatment visit was not followed by a PHQ-9, a deviation from the protocol. Today's PHQ-2 is 1 and he reports a steady mood, so no harm is evident; a PHQ-9 will follow any PHQ-2 of 2 or more |
| Referral | Speech-language pathology swallowing review | After treatment and as needed | Referred | Referred for a post-treatment swallowing assessment |
| Referral | Dietitian follow-up | During recovery | Referred | To help him regain weight; albumin 3.3 |
| Referral | Dental review with daily fluoride | Every 6 months after neck radiation | Up to date | Dental evaluation done before radiation; fluoride trays nightly |
| Examination | Hearing and ear symptoms | Each follow-up visit | Completed today | No hearing change or ear pain |
| Self-management | Tobacco use status and cessation counseling | Every visit | Completed today | No cigars for about fourteen weeks; relapse-prevention counseling given |
| Medication safety | Varenicline tolerance: nausea, sleep, mood, and behavior | Each visit during treatment | Completed today | No side effects; continued to complete about 24 weeks in all |
| Medication safety | Influenza vaccine | Every season | Completed today | Given today |
Goal progress:
Immunizations given today: Influenza vaccine, 1884-1885 season [S]
Guideline basis: NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2025 (2025); Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions (2021); CMID: Clinical Monitoring Intelligence Database, depression and hypothyroidism monographs (2026); American Cancer Society Head and Neck Cancer Survivorship Care Guideline (2016)
Follow-up: Head and neck oncology follow-up in the coming weeks and post-treatment PET/CT about 12 weeks after treatment. Primary care visit in four to six weeks with a CBC and basic metabolic panel. [S]